Literature DB >> 6751163

Autoantibodies in thromboangiitis obliterans (Buerger's disease).

S M Gulati, K Madhra, T K Thusoo, S K Nair, K Saha.   

Abstract

Autoantibodies, organ and non-organ specific, were studied in 10 patients of thromboangiitis obliterans by immunofluorescence technique and compared with age matched controls without peripheral vascular disease and patients of other peripheral vascular diseases. Organ specific autoantibodies (various classes of immunoglobulins IgM, IgG, IgA) and C3 component were observed in the diseased vessels of thromboangiitis obliterans. Antibodies, antiarterial, were present in the sera of these patients. Among the non-organ specific antibodies (ANA and AMA), only ANA were found in the sera of patients. Presence of autoantibodies in patients of thromboangiitis obliterans strongly point out of that probably this disease entity is an autoimmune disorder.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6751163     DOI: 10.1177/000331978203301003

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  5 in total

1.  Buerger's Disease; Any Current Advances?

Authors:  Yong-Bok Koh
Journal:  Ann Vasc Dis       Date:  2008-10-24

2.  Successful treatment of thromboangiitis obliterans (Buerger's disease) with immunoadsorption: results of a pilot study.

Authors:  Gert Baumann; Verena Stangl; Peter Klein-Weigel; Karl Stangl; Michael Laule; Kathrin Enke-Melzer
Journal:  Clin Res Cardiol       Date:  2011-03-05       Impact factor: 5.460

3.  Thromboangiitis obliterans: current perspectives and future directions.

Authors:  A Ansari
Journal:  Tex Heart Inst J       Date:  1990

Review 4.  Current status of patients with buerger disease in Japan.

Authors:  Noriyuki Hida; Takashi Ohta
Journal:  Ann Vasc Dis       Date:  2013-08-12

Review 5.  Buerger's disease: providing integrated care.

Authors:  Peter Klein-Weigel; Theresa Sophie Volz; Leonora Zange; Jutta Richter
Journal:  J Multidiscip Healthc       Date:  2016-10-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.